Literature DB >> 26835265

Vertebral compression fractures during chemotherapy for childhood acute lymphoblastic leukemia: commentary on a report from the STeroid Associated Osteoporosis in the Pediatric Population (STOPP) research program.

Kirsten K Ness1, Wassim Chemaitilly1, Sue C Kaste1.   

Abstract

Entities:  

Year:  2012        PMID： 26835265      PMCID： PMC4728880          DOI： 10.3978/j.issn.2224-4336.2012.09.04

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN： 2224-4336


× No keyword cloud information.
  20 in total

1.  High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy.

Authors:  Nathalie Alos; Ronald M Grant; Timothy Ramsay; Jacqueline Halton; Elizabeth A Cummings; Paivi M Miettunen; Sharon Abish; Stephanie Atkinson; Ronald Barr; David A Cabral; Elizabeth Cairney; Robert Couch; David B Dix; Conrad V Fernandez; John Hay; Sara Israels; Caroline Laverdière; Brian Lentle; Victor Lewis; MaryAnn Matzinger; Celia Rodd; Nazih Shenouda; Robert Stein; David Stephure; Shayne Taback; Beverly Wilson; Kathryn Williams; Frank Rauch; Kerry Siminoski; Leanne M Ward
Journal:  J Clin Oncol       Date:  2012-06-25       Impact factor: 44.544

2.  Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998.

Authors:  N Kadan-Lottick; J A Marshall; A E Barón; N F Krebs; K M Hambidge; E Albano
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

3.  Predictors of bony morbidity in children with acute lymphoblastic leukemia.

Authors:  Meera S Rayar; Trishana Nayiager; Colin E Webber; Ronald D Barr; Uma H Athale
Journal:  Pediatr Blood Cancer       Date:  2011-12-20       Impact factor: 3.167

4.  Risk of new vertebral fracture in the year following a fracture.

Authors:  R Lindsay; S L Silverman; C Cooper; D A Hanley; I Barton; S B Broy; A Licata; L Benhamou; P Geusens; K Flowers; H Stracke; E Seeman
Journal:  JAMA       Date:  2001-01-17       Impact factor: 56.272

5.  Impact of degenerative radiographic abnormalities and vertebral fractures on spinal bone density of women with osteoporosis.

Authors:  Lúcia Costa Paiva; Silvana Filardi; Aarão Mendes Pinto-Neto; Adil Samara; João Francisco Marques Neto
Journal:  Sao Paulo Med J       Date:  2002-01-03       Impact factor: 1.044

6.  Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.

Authors:  Mary V Relling; Wenjian Yang; Soma Das; Edwin H Cook; Gary L Rosner; Michael Neel; Scott Howard; Raul Ribeiro; John T Sandlund; Ching-Hon Pui; Sue C Kaste
Journal:  J Clin Oncol       Date:  2004-10-01       Impact factor: 44.544

7.  Toxicity of bisphosphonates.

Authors:  Eric E Prommer
Journal:  J Palliat Med       Date:  2009-11       Impact factor: 2.947

8.  Bisphosphonate therapy for reduced bone mineral density during treatment of acute lymphoblastic leukemia in childhood and adolescence: a report of preliminary experience.

Authors:  Christopher Lethaby; John Wiernikowski; Alessandra Sala; Marissa Naronha; Colin Webber; Ronald D Barr
Journal:  J Pediatr Hematol Oncol       Date:  2007-09       Impact factor: 1.289

Review 9.  Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.

Authors:  Karen Wasilewski-Masker; Sue C Kaste; Melissa M Hudson; Natia Esiashvili; Leonard A Mattano; Lillian R Meacham
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

10.  Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.

Authors:  Stephen Gehlbach; Kenneth G Saag; Jonathan D Adachi; Fred H Hooven; Julie Flahive; Steven Boonen; Roland D Chapurlat; Juliet E Compston; Cyrus Cooper; Adolfo Díez-Perez; Susan L Greenspan; Andrea Z LaCroix; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Philip N Sambrook; Stuart Silverman; Ethel S Siris; Nelson B Watts; Robert Lindsay
Journal:  J Bone Miner Res       Date:  2012-03       Impact factor: 6.741
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.